Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

Authors : Amrita Shah, Pradeep Rangappa, Ipe Jacob, Karthik Rao, Neelesh Reddy

DOI : 10.18231/j.ijpo.2022.096

Volume : 9

Issue : 4

Year : 2022

Page No : 392-394


 


Citation Data


Related Articles

Coronavirus- The origin

Uma Pandey, Megha Garg

Comparative evaluation of radiographic density of different endodontic material

Vikaskumar N Patel*, Bapanaiah Penugonda, Anuja Patel

Denture adhesive

Komal Khond Warghane, Pratik Hodar

Pharmacovigilance in India and five ASEAN countries (Malaysia, Singapore, Thailand, Indonesia, Philippines): A comparison study

Avisek Dutta, Anupam Banerjee, Piyali Pramanik, Neha Pradhan, Sunil Chaudhry

Clinicopathological analysis of abnormal uterine bleeding in reproductive and post menopausal women in a tertiary care centre of south eastern part of India

Rupal Samal, Anandraj Vaithy, Shanmugasamy, Syed Habeebullah

Management of recurrent apthous stomatitis-current trends & perspective

Akhilanand Chaurasia, Akansha Vatsa

A comparative study between emergency department provisional diagnoses and final discharge diagnoses in tertiary and quaternary health centers of India

Priyanka Patel, Kuldeep Kumar Ashta, Yamini Subramani, Sumit Kumar Ghosh

Safety concerns of dietary and herbal supplements for typical patients

Swapan Banerjee

A comparative assessment of daily dosage regimen versus intermittent treatment regimen of tuberculosis at the RNTCP centres in Chitradurga district

Karnappa Bhangari, Basavaraj S Sangolli, Jagadeesha H N